Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
about
Antioxidant treatments for schizophreniaOlanzapine versus other atypical antipsychotics for schizophreniaAntioxidant supplements for prevention of mortality in healthy participants and patients with various diseasesOxidative stress in schizophreniaNutritional interventions for the adjunctive treatment of schizophrenia: a brief reviewAntioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Meta-analysis of oxidative stress in schizophrenia.The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis.Oxidative stress in schizophrenia: an integrated approach.Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics.Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia.Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative studyEfficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study.Antioxidants as potential therapeutics for neuropsychiatric disorders.Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophreniaVitamin C in disease prevention and cure: an overviewA randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy.Vitamin supplementation in the treatment of schizophrenia.Lipid peroxidation in psychiatric illness: overview of clinical evidenceFatty acid and vitamin interventions in adults with schizophrenia: a systematic review of the current evidence.The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.Ascorbic Acid to Manage Psychiatric Disorders.Sulforaphane protects SK-N-SH cells against antipsychotic-induced oxidative stress.Neuroprotection of paliperidone on SH-SY5Y cells against β-amyloid peptide(25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death.Neuroprotection in Schizophrenia and Its Therapeutic Implications.Study of oxidative stress in obsessive compulsive disorder in response to treatment with Fluoxetine.A comparative study of oxidative stress and interrelationship of important antioxidants in haloperidol and olanzapine treated patients suffering from schizophrenia.Antipsychotic-like effect of minocycline in a rat model.Effects of antipsychotics and vitamin C on the formation of reactive oxygen species.Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis.Lower antioxidant capacity in the prefrontal cortex of individuals with schizophrenia.Assessment of novel iloperidone- and idebenone-loaded nanostructured lipid carriers: brain targeting efficiency and neuroprotective potential.Natural Medicines for Psychotic Disorders: A Systematic Review.Adjunctive nutrients in first-episode psychosis: A systematic review of efficacy, tolerability and neurobiological mechanisms.Antipsychotic-like effect of trimetazidine in a rodent model.
P2860
Q24186162-32516F49-AAE6-4B05-8F49-DCBED73EC0F4Q24236545-398065C2-21E3-4619-8D09-B5D23C87C2D8Q24242944-82D45E2F-CA4A-4100-86AC-1552A8F685D3Q24595660-5EC2C55A-DF08-4C82-8F55-2090F663A260Q28248117-3D84CEF9-9CD2-41C8-9F6B-9CCDE5A3E517Q33350202-4E559B8E-ED22-474A-A664-A632DF5536F9Q33601360-60F5EBC1-A000-4B2A-8707-156820414101Q34047983-9155F3B2-A121-4B58-8E5C-C62A08003E44Q34494844-F66EAB1F-68F5-4F50-B47C-B0E58BEB23EEQ34786239-F82875AC-4A7F-4AB0-B3AC-F2F34BA86B30Q35084781-FD7F6D48-88F2-4D06-BB99-1D000C08BA7FQ35166850-3DB08ED7-FCC2-4825-9744-ACB555B1B768Q36690533-1434481C-1B81-4EFB-AD70-D2E87A95098BQ36736055-627FB16F-4C6E-46E5-9379-06CEFD5C7FA6Q36923043-573F576E-BDBB-42AC-A013-9680162EF201Q37199413-3D33763F-8503-46A7-8319-CEB126DEB0F9Q37530729-5E384BC1-EBD1-43C8-8BD0-6845E2E6F16FQ38086474-7A417D3C-EF0A-46D8-BE26-36314C7B5C40Q38213305-AA01D0EB-49E7-4ACD-8AE4-B829DCE8FD62Q38215504-88C9F578-8EF6-45C0-B374-F64487876FF9Q38583706-8B47C7D5-DBE6-43FF-9B2D-97ABE77ABF7AQ38780915-738222FE-EEAF-4162-AD33-ADA16715A188Q39363527-1795C4C9-6304-4667-AE77-5AC7CF4E51BEQ39472796-AB388355-F480-4494-86A0-4F4816A5D887Q39552320-A3AC1444-BDA0-44B0-B451-2BF2E536AAD0Q41449646-1544B987-8B57-45AE-9804-DA0BFA75C769Q42257861-7D66EFA9-8275-447B-B9BF-D06D27236CE3Q42546729-50866CD0-6F90-41BB-8D63-EB03E068C798Q43015622-F07DDF3E-B57C-44AE-8B12-4A31F516CCF5Q46090406-E8434D20-B36F-41B2-BCC9-C6EF66DF6B67Q47567371-39250017-6053-42FB-89A8-03BFD7E1E90EQ47824619-0D134D0E-2A4D-4609-820A-3DFA06B51E20Q48873833-BE130197-8BDB-4EB2-8977-5E75A5C4A168Q49363880-FA8E3B71-0A73-46D8-8E20-7663F074B9A2Q52645449-C6EAD40B-6405-4A17-9A4A-4C9D54769AC9Q54574268-6C8DAEFA-7A8F-4AB1-BCEF-4C6F392DBDB5
P2860
Supplementation of vitamin C with atypical antipsychotics reduces oxidative stress and improves the outcome of schizophrenia
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@ast
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@en
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@nl
type
label
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@ast
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@en
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@nl
prefLabel
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@ast
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@en
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@nl
P2093
P921
P1433
P1476
Supplementation of vitamin C w ...... s the outcome of schizophrenia
@en
P2093
G N Dakhale
S D Khanzode
S S Khanzode
P2888
P356
10.1007/S00213-005-0117-1
P407
P577
2005-11-01T00:00:00Z
P6179
1041780235